Cardiovascular primary prevention - directed approach for individual features
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000200007 |
Resumo: | Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as one-dose-fits-all strategy remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification. |
id |
RCAP_6348a7346e5920096da0128a33176d80 |
---|---|
oai_identifier_str |
oai:scielo:S0872-01692019000200007 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Cardiovascular primary prevention - directed approach for individual featurescardiovascular primary preventioncardiovascular risk factorscardiovascular diseaselifestyle changesCardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as one-dose-fits-all strategy remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification.Sociedade Portuguesa de Nefrologia2019-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000200007Portuguese Journal of Nephrology & Hypertension v.33 n.2 2019reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000200007Mano,Tânia BrancoRosa,Sílvia AguiarRio,PedroTimóteo,Ana TeresaFerreira,Rui Cruzinfo:eu-repo/semantics/openAccess2024-02-06T17:05:02Zoai:scielo:S0872-01692019000200007Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:19:02.342589Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Cardiovascular primary prevention - directed approach for individual features |
title |
Cardiovascular primary prevention - directed approach for individual features |
spellingShingle |
Cardiovascular primary prevention - directed approach for individual features Mano,Tânia Branco cardiovascular primary prevention cardiovascular risk factors cardiovascular disease lifestyle changes |
title_short |
Cardiovascular primary prevention - directed approach for individual features |
title_full |
Cardiovascular primary prevention - directed approach for individual features |
title_fullStr |
Cardiovascular primary prevention - directed approach for individual features |
title_full_unstemmed |
Cardiovascular primary prevention - directed approach for individual features |
title_sort |
Cardiovascular primary prevention - directed approach for individual features |
author |
Mano,Tânia Branco |
author_facet |
Mano,Tânia Branco Rosa,Sílvia Aguiar Rio,Pedro Timóteo,Ana Teresa Ferreira,Rui Cruz |
author_role |
author |
author2 |
Rosa,Sílvia Aguiar Rio,Pedro Timóteo,Ana Teresa Ferreira,Rui Cruz |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Mano,Tânia Branco Rosa,Sílvia Aguiar Rio,Pedro Timóteo,Ana Teresa Ferreira,Rui Cruz |
dc.subject.por.fl_str_mv |
cardiovascular primary prevention cardiovascular risk factors cardiovascular disease lifestyle changes |
topic |
cardiovascular primary prevention cardiovascular risk factors cardiovascular disease lifestyle changes |
description |
Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as one-dose-fits-all strategy remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-06-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000200007 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000200007 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000200007 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
dc.source.none.fl_str_mv |
Portuguese Journal of Nephrology & Hypertension v.33 n.2 2019 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137280168820736 |